28Jun
[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action
Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By:
Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/
Related
Federal construction contractors are wise to take note of two major developments involving their com...
Read More >
Deadlines are approaching for employers to report the year’s employee exercises of incentive stock ...
Read More >
Equal pay for equal work is a hot topic for employers. In the last few years, several states have pa...
Read More >
A new Virginia statute limits employers’ use of nondisclosure and confidentiality agreements with r...
Read More >
Carbon capture technology has made great advancements in recent years and Section 45Q of the Interna...
Read More >
Employees who take FMLA leave may be required to comply with the employer’s usual and customary not...
Read More >